Compassionate use of cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> prosthetic joint infection

Abstract

Cefiderocol's novel mode of cell entry is effective against MDR Gram-negative bacteria with reduced toxicity compared with other last line antibiotics. Our case demonstrates that cefiderocol may be useful as therapy for patients with limited treatment options due to antimicrobial resistance.